Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Manufacturing & Bioprocessing
Future Directions for Accelerated Upstream Bioprocessing
Key opinion leaders from Novartis, Achilles Therapeutics, and AbbVie divulge their views on what's next for upstream bioprocessing.
Immunotherapy (Non-Oncology)
Treating Autoimmune Diseases: Past, Present, and Future
Bringing together the experts to discuss the timeline of autoimmune disease therapeutics.
Tumour Microenvironment
Tackling Solid Tumours in Immuno-Oncology
What’s next for CAR T cell therapy? What’s the best way to develop combination therapies for multi-modal efficacy?
Manufacturing & Bioprocessing
Digital Twins: Upstream Processing Applications and Hybrid Models
This Commentary article investigates the potential applications of digital twins in refining the developmental timeline for drug substance development. Capturing and conserving the understanding from ongoing processes allows researchers to learn more about the intricacies of the developmental process more rapidly.
Peptide Chemistry
Peptide Production: Biopharmaceutical Manufacturing of Next Generation Peptides
In this Commentary article, we explore how innovative technologies like expression tags could help to overcome challenges associated with recombinant peptide production. The potential for recombinant production to slash manufacturing costs has made it a focal area of research for companies such as Boehringer Ingelheim.
Peptide Chemistry
Peptide Discovery: Unlocking the Future of Disruptive Therapeutics
UCB, Bicycle Therapeutics, and Sanofi share their latest findings in Peptide discovery at Biologics UK 2022.
Antibody & Protein Engineering
Advanced Antibody Engineering: AI, ML, and Computational Tools
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our April Discussion Group addressing ‘Accelerating Antibody Engineering With AI/ML & Advanced Computational Tools and Technologies’ brought together an exclusive panel of key opinion leaders to address the market’s growth and future outlook.
Drug Discovery & Development
Targeting Solid Tumours With TCR Guided NK Cells
Video Interview | Namir Hassan, CEO at Zelluna Immunotherapy
3D Cell Culture
Understanding Disease Progression with 3D Model Development
Will 3D model development reach its potential to innovate cell and gene therapeutics? We spoke to Merck, GlaxoSmithKline, East Carolina University Brody School of Medicine, and the Institute of Molecular Biotechnology to find out more.
3D Cell Culture
3D Model Development
Oxford Global's Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our April Discussion Group addressing ‘3D Model Development' brought together an exclusive panel of key opinion leaders to address the market's growth and future directions.
Antibody & Protein Engineering
What’s Next for Antibody-Based Therapeutic Discovery and Optimisation?
As market leaders in the biologics field, there is no sign of demand for antibody-based therapies slowing down any time soon. With exclusive insights from the CRUK-AstraZeneca Antibody Alliance Laboratory, we look towards the future of antibody discovery and optimisation.
3D Cell Culture
Tackling Tumours In-Vitro with 3D Cell Cultures
Raymond R. Mattingly explains the applications of 3D cell culturing at Oxford Global's 3D Cell Culture Symposium.